Coronary artery disease/冠狀動脈疾病

上官良治https://en.wikipedia.org/wiki/Wikipedia:WikiProject_Medicine/Translation_task_force/RTT/Simple_CAD

 

{{Infobox disease

| Name = 冠狀動脈疾病 / Coronary artery disease

| Image = Blausen 0257 CoronaryArtery Plaque.png

| Caption = 冠狀動脈粥樣硬化示意圖

| DiseasesDB =

| ICD10 = {{ICD10|I|20||i|20}}-{{ICD10|I|25||i|20}}

| ICD9 = {{ICD9|410}}-{{ICD9|414}}, {{ICD9|429.2}}

| ICDO =

| OMIM =

| MedlinePlus = 007115

| eMedicineSubj = radio

| eMedicineTopic = 192

| MeshID = D003324

}}

 

WATSON LCoronary artery disease (CAD), also known as ischemic heart disease (IHD),[1] atherosclerotic heart disease,[2]atherosclerotic cardiovascular disease,[3] and coronary heart disease,[4] is a group of diseases that includes: stable angina,unstable angina, myocardial infarction, and sudden coronary death.[5] It is within the group of cardiovascular diseases of which it is the most common type.[6] A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw.[7] Occasionally it may feel like heartburn.[7] Usually symptoms occur with exercise or emotional stress lasts less than a few minutes and get better with rest.[7] Shortness of breath may also occur and sometimes no symptoms are present.[7] The first sign is occasionally a heart attack.[8] Other complications include heart failure or an irregular heartbeat.[8]

<!-- 定義與症狀 -->

上官良治'''冠狀動脈疾病'''({{lang-en|Coronary artery disease, CAD}})又稱為'''缺血性心臟病'''或簡稱'''冠心病'''({{lang-en|ischemic heart disease, IHD}})[1]、'''冠狀動脈粥狀硬化心臟病'''[2]、'''冠狀動脈粥狀硬化心血管疾病'''({{lang-en|coronary atherosclerotic heart disease, '''CAHD'''}})[3]和'''冠狀動脈心臟病'''({{lang-en|coronary heart disease}})[4],是一群包含穩定型[[心絞痛]]、{{Link-en|非穩定型心絞痛|Unstable angina}}、[[心肌梗塞]]和[[猝死]]的疾病[5]。冠狀動脈疾病是最常見的[[心血管疾病|心臟血管疾病]][6]。常見的症狀包括{{link-en|胸痛|chest pain}}或不適,有時會轉移到肩膀、手臂、背部、頸部或下顎[7]。有些人可能會有{{Link-en|胸口灼熱|Heartburn}}的感覺[7]。通常症狀在運動或情緒壓力下出現,持續時間不超過數分鐘且休息會緩解[7]。有時會伴隨[[呼吸困難]],有時則是毫無症狀[7]。少數人以[[心肌梗塞]]為最初的表現[8]。其他可能的併發症包含[[心臟衰竭]]或[[心律不整]][8]。

    Watson Lin[1]
    Watson Lin<ref>{{cite book |last=Bhatia |first=Sujata K. |title=Biomaterials for clinical applications |year=2010|publisher=Springer |location=New York |isbn=9781441969200 |page=23|url=http://books.google.ca/books?id=bXtaX468LRYC&pg=PA23 |edition=Online-Ausg.}}</ref>
    Watson Lin[2]
    Watson Lin<ref>{{cite web |title=Coronary heart disease - causes, symptoms, prevention |url=https://www.southerncross.co.nz/AboutTheGroup/HealthResources/MedicalLibrary/tabid/178/vw/1/ItemID/191/ |work=Southern Cross Healthcare Group |accessdate=15 September 2013}}</ref>
    Watson Lin[3]
    Watson Lin<ref>{{cite journal|last1=Faxon|first1=D. P.|title=Atherosclerotic Vascular Disease Conference: Executive Summary: Atherosclerotic Vascular Disease Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association|journal=Circulation|date=1 June 2004|volume=109|issue=21|pages=2595–2604|doi=10.1161/01.CIR.0000128517.52533.DB}}</ref>
    Watson Lin[4]
    Watson Lin<ref>{{cite web |title=Coronary heart disease |url=http://www.nlm.nih.gov/medlineplus/ency/article/007115.htm |publisher=ADAM |accessdate=15 September 2013 }}</ref>
    Watson Lin[5]
    Watson Lin<ref name=Wong2014>{{cite journal|last1=Wong|first1=ND|title=Epidemiological studies of CHD and the evolution of preventive cardiology.|journal=Nature reviews. Cardiology|date=May 2014|volume=11|issue=5|pages=276-89|pmid=24663092}}</ref>
    Watson Lin[6]
    Watson Lin<ref name=GDB2013>{{cite journal|last1=GBD 2013 Mortality and Causes of Death|first1=Collaborators|title=Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.|journal=Lancet|date=17 December 2014|pmid=25530442|doi=10.1016/S0140-6736(14)61682-2}}</ref>
    Watson Lin[7]
    Watson Lin<ref name=HLB2014>{{cite web|title=What Are the Signs and Symptoms of Coronary Heart Disease?|url=http://www.nhlbi.nih.gov/health/health-topics/topics/cad/signs|website=http://www.nhlbi.nih.gov/|accessdate=23 February 2015|date=September 29, 2014}}</ref>
    Watson Lin[8]
    Watson Lin<ref name=CDC2013>{{cite web|title=Coronary Artery Disease (CAD)|url=http://www.cdc.gov/heartdisease/coronary_ad.htm|website=cdc.gov|accessdate=23 February 2015|date=March 12, 2013}}</ref>

 

WATSON LRisk factors include: high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol, among others.[9][10] Other risks include depression.[11] The underlying mechanism involves atherosclerosis of the arteries of the heart.[10] A number of tests may help with diagnoses including: electrocardiogram, cardiac stress testing, and coronary angiogram among others.[12]

<!--成因與診斷 -->

AARON K危險因子包括:[[高血壓]]、[[吸菸|抽菸]]、[[糖尿病]]、缺乏運動、[[肥胖症|肥胖]]、{{Link-en|血液中膽固醇含量過高|Hypercholesterolemia}}、營養不良和酗[[乙醇|酒]]等[9][10]。其他的危險因子也包括[[重性憂鬱障礙|憂鬱症]][11]。潛在的病理機制與[[冠狀血管|冠狀動脈血管]]的[[動脈粥樣硬化|粥狀硬化]]有關[10]。[[心電圖]]、{{Link-en|心臟壓力測試|Cardiac stress test}}與{{Link-en|冠狀動脈血管攝影|Coronary catheterization}}是常見有助於診斷的工具[12]。

    Watson Lin[9]
    Watson Lin<ref>{{cite journal|last1=Mehta|first1=PK|last2=Wei|first2=J|last3=Wenger|first3=NK|title=Ischemic heart disease in women: A focus on risk factors.|journal=Trends in cardiovascular medicine|date=16 October 2014|pmid=25453985}}</ref>
    Watson Lin[10]
    Watson Lin<ref name=WHO2011>{{cite book|last2=Mendis|first2=Shanthi|last3=Puska,|first3=Pekka|last4=Norrving|first4=Bo|title=Global atlas on cardiovascular disease prevention and control|date=2011|publisher=World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization|location=Geneva|isbn=9789241564373|pages=3-18|edition=1st ed.|url=http://whqlibdoc.who.int/publications/2011/9789241564373_eng.pdf?ua=1}}</ref>
    Watson Lin[11]
    Watson Lin<ref>{{cite journal|last1=Charlson|first1=FJ|last2=Moran|first2=AE|last3=Freedman|first3=G|last4=Norman|first4=RE|last5=Stapelberg|first5=NJ|last6=Baxter|first6=AJ|last7=Vos|first7=T|last8=Whiteford|first8=HA|title=The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment.|journal=BMC medicine|date=26 November 2013|volume=11|pages=250|pmid=24274053}}</ref>
    Watson Lin[12]
    Watson Lin<ref>{{cite web|title=How Is Coronary Heart Disease Diagnosed?|url=http://www.nhlbi.nih.gov/hecdalth/health-topics/topics/cad/diagnosis|website=http://www.nhlbi.nih.gov/|accessdate=25 February 2015|date=September 29, 2014}}</ref>

 

WATSON LPrevention is by eating a healthy diet, regular exercise, maintaining a healthy weight and not smoking.[13] Sometimes medication for diabetes, high cholesterol, or high blood pressure are also used.[13] There is limited evidence for screening people who are at low risk and do not have symptoms.[14] Treatment involves the same measures as prevention.[15][16] Additional medications such as aspirin beta blockers, or nitrogylcerin may be recommended.[16] Procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG) may be used in severe disease.[16][17] In those with stable CAD it is unclear if PCI or CABG in addition to the other treatments improve life expectancy or decreases heart attack risk.[18]

<!--預防與治療-->

AARON K預防方式包括:健康飲食、規律運動、體重控制以及戒菸[13]。視情況合併使用藥物控制高血糖、高膽固醇或高血壓[13]。只有很有限的證據支持對低風險且沒有症狀的民眾實施篩檢[14]。最初治療和預防措施一樣,包括生活方式調整以及三高(高血糖、高膽固醇或高血壓)的控制[15][16]。進一步的藥物治療包括[[阿斯匹靈]]、{{link-en|乙型交感神經阻斷劑|Beta_blocker}}或{{link-en|硝酸甘油|Medical_use_of_nitroglycerin|硝酸甘油的醫療用途}}[16]。在病況較嚴重的情形下,會考慮進行[[冠狀動脈再成形術|經皮冠狀動脈介入治療]]({{lang-en|percutaneous coronary intervention, PCI}})或是[[冠狀動脈搭橋手術|冠狀動脈繞道手術]]({{lang-en|coronary artery bypass surgery, CABG}})[16][17]。對於穩定型心絞痛,經皮冠狀動脈介入治療或是冠狀動脈繞道手術,對於提升存活年限或降低未來心臟病發的效果仍不明確[18]。

    Watson Lin[13]
    Watson Lin<ref name=HLB2013P>{{cite web|title=How Can Coronary Heart Disease Be Prevented or Delayed?|url=http://www.nhlbi.nih.gov/health/health-topics/topics/cad/prevention|website=http://www.nhlbi.nih.gov/|accessdate=25 February 2015}}</ref>
    Watson Lin[14]
    Watson Lin<ref>{{cite journal|last1=Desai|first1=CS|last2=Blumenthal|first2=RS|last3=Greenland|first3=P|title=Screening low-risk individuals for coronary artery disease.|journal=Current atherosclerosis reports|date=April 2014|volume=16|issue=4|pages=402|pmid=24522859}}</ref>
    Watson Lin[15]
    Watson Lin<ref>{{cite journal|last1=Boden|first1=WE|last2=Franklin|first2=B|last3=Berra|first3=K|last4=Haskell|first4=WL|last5=Calfas|first5=KJ|last6=Zimmerman|first6=FH|last7=Wenger|first7=NK|title=Exercise as a therapeutic intervention in patients with stable ischemic heart disease: an underfilled prescription.|journal=The American journal of medicine|date=October 2014|volume=127|issue=10|pages=905-11|pmid=24844736}}</ref>
    Watson Lin[16]
    Watson Lin<ref name=HLB2013Tr>{{cite web|title=How Is Coronary Heart Disease Treated?|url=http://www.nhlbi.nih.gov/health/health-topics/topics/cad/treatment|website=http://www.nhlbi.nih.gov/|accessdate=25 February 2015|date=September 29, 2014}}</ref>
    Watson Lin[17]
    Watson Lin<ref>{{cite journal|last1=Deb|first1=S|last2=Wijeysundera|first2=HC|last3=Ko|first3=DT|last4=Tsubota|first4=H|last5=Hill|first5=S|last6=Fremes|first6=SE|title=Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.|journal=JAMA|date=20 November 2013|volume=310|issue=19|pages=2086-95|pmid=24240936}}</ref>
    Watson Lin[18]
    Watson Lin<ref>{{cite journal|last1=Rezende|first1=PC|last2=Scudeler|first2=TL|last3=da Costa|first3=LM|last4=Hueb|first4=W|title=Conservative strategy for treatment of stable coronary artery disease.|journal=World journal of clinical cases|date=16 February 2015|volume=3|issue=2|pages=163-70|pmid=25685763}}</ref>

 

WATSON LIn 2013 CAD was the most common cause of death globally, resulting in 8.14 million deaths (16.8%) up from 5.74 million deaths (12%) in 1990.[6] The risk of death from CAD for a given age has decreased between 1980 and 2010 especially in the developed world.[19] The number of cases of CAD for a given age has also decreased between 1990 and 2010.[20] In the United States in 2010 about 20% of those over 65 had CAD, while it was present in 7% of those 45 to 64, and 1.3% of those 18 to 45.[21] Rates are higher among men than women of a given age.[21]

<!--流行病學 -->

AARON K冠狀動脈疾病在西元在2012年是[[2002年致死原因及所占比例列表|全球第一大死因]][中1],也是人們住院的主要原因之一[中2]2013年也是全球死因首位,死亡人數自1990年574萬人(12%)攀升至2013年814萬人(16.8%)[6]。而隨著診斷及治療技術進步,經年齡校正後的冠狀動脈疾病死亡率自1980年至2010年則呈現下降趨勢,尤其在[[已開發國家]]更為顯著[19]。同時經年齡校正後的冠狀動脈疾病病例數在1990至2010年間亦呈現下降趨勢[20]。根據美國本土於2010年統計,冠狀動脈疾病盛行率於大於65歲族群為20%、45至64歲為7%、18至45歲為1.3%[21]。針對同一年齡層相比,男性的發生率較女性高[21]。

    Watson Lin看不懂8.14 million deaths (16.8%) up from 5.74 million deaths (12%) in 1990當中12%及16.8%指的是什麼的百分比,應該不是死亡率(太高),難道是指占所有死亡原因的百分比嗎?
    Aaron Kosatern指的是所有死亡原因的百分比。
    上官良治有個地方已開發國家翻譯成了開發中 XD 修好了,但原文連結有個問題,他連到的全球死因統計是2002年的資料,那2013全球第一大死因的資料是哪來的 ?! 我在條目討論串上發言,問英文維基百科審定版的作者 ,等他回答了。
    Watson Lin[19]
    Watson Lin<ref>{{cite journal|last1=Moran|first1=AE|last2=Forouzanfar|first2=MH|last3=Roth|first3=GA|last4=Mensah|first4=GA|last5=Ezzati|first5=M|last6=Murray|first6=CJ|last7=Naghavi|first7=M|title=Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.|journal=Circulation|date=8 April 2014|volume=129|issue=14|pages=1483-92|pmid=24573352}}</ref>
    Watson Lin[20]
    Watson Lin <ref>{{cite journal|last1=Moran|first1=AE|last2=Forouzanfar|first2=MH|last3=Roth|first3=GA|last4=Mensah|first4=GA|last5=Ezzati|first5=M|last6=Flaxman|first6=A|last7=Murray|first7=CJ|last8=Naghavi|first8=M|title=The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.|journal=Circulation|date=8 April 2014|volume=129|issue=14|pages=1493-501|pmid=24573351}}</ref>
    Watson Lin[21]
    Watson Lin<ref name=US2011>{{cite journal|last1=Centers for Disease Control and Prevention|first1=(CDC)|title=Prevalence of coronary heart disease--United States, 2006-2010.|journal=MMWR. Morbidity and mortality weekly report|date=14 October 2011|volume=60|issue=40|pages=1377-81|pmid=21993341}}</ref>

 

    上官良治將中文維基百科引言的三段資料分別放入適當脈絡了
    上官良治[中1]
    上官良治<ref name=Finegold>{{cite journal |last=Finegold |first=JA |coauthors=Asaria, P; Francis, DP |title=Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations |journal=International journal of cardiology|date=4 December 2012 |pmid=23218570|doi=10.1016/j.ijcard.2012.10.046|volume=168|issue=2|pages=934–45}}</ref>
    上官良治
    上官良治[中2]
    上官良治<ref name=WHO>{{cite book|author=World Health Organization Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster |title=The global burden of disease 2004 update |publisher=WHO |location=Geneva |year=2004 |isbn=92-4-156371-0}}</ref>

 

鼎淵 藍2015-03-29 已整合此篇至中文維基百科「冠狀動脈疾病」條目

上官良治回到工作入口頁